-N Mitsiades Researcher Activity Profile

Research Author Detailed Information 

N Mitsiades Publication Rate By Year

N Mitsiades has published 1 paper(s) in 2001, 2 paper(s) in 2005, 1 paper(s) in 2006, 5 paper(s) in 2007, for a total of 9 research publications in total.

N N Mitsiades Author Information

LAST NAME: mitsiades

FIRST NAME: N

INITIALS: n

AFFILIATION:

Papers

N Mitsiades's Publication Record

1. Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies. Year Published: 2001
Department of Adult Oncology, Dana Farber Cancer Institute,Boston Massachusetts 02115, USA.
2. Proteasome inhibition as a new therapeutic principle in hematological malignancies. Year Published: 2006
Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA. Constantine_Mitsiades@dfci.harvard.edu
3. Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM). Year Published: 2007
The Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
4. Proteasome inhibition as a therapeutic strategy for hematologic malignancies. Year Published: 2005
Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA, USA. Constantine_Mitsiades@dfci.harvard.edu
5. Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling. Year Published: 2005
Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Department of Medicine, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA. Constantine_Mitsiades@dfci.harvard.edu
6. Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to bcl-2 homology 3 domain inhibition. Year Published: 2007
Department of Medical Oncology, Dana Farber Cancer Institute, Mayer Building, Room M555, 44 Binney Street, Boston, Massachusetts 02115. constantine_mitsiades@dfci.harvard.edu.
7. Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition. Year Published: 2007
Department of Medical Oncology, Dana Farber Cancer Institute, Mayer Building, Room M555, 44 Binney Street, Boston, Massachusetts 02115, USA. constantine_mitsiades@dfci.harvard.edu
8. Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition. Year Published: 2007
Department of Medical Oncology, Dana Farber Cancer Institute, Mayer Building, Room M555, 44 Binney Street, Boston, Massachusetts 02115, USA. constantine_mitsiades@dfci.harvard.edu
9. Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease. Year Published: 2007
Permanente Medical Group, Fremont, California, USA.